Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responsesElke Stein, Thomas O. Daniel, Andrew A. Lane et al.|Genes & Development|1998Cited by 424
Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid LeukemiaYi‐Bin Chen, Robert J. Soiffer, Joseph H. Antin et al.|Biology of Blood and Marrow Transplantation|2014Cited by 234
Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to VenetoclaxJoan Montero, Andrew A. Lane, Jason Stephansky et al.|Cancer Discovery|2016Cited by 209
Nck Recruitment to Eph Receptor, EphB1/ELK, Couples Ligand Activation to c-Jun KinaseElke Stein, Thomas O. Daniel, Uyen Huynh‐Do et al.|Journal of Biological Chemistry|1998Cited by 150
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemiaAndrew A. Lane, Naveen Pemmaraju, Jacqueline S. Garcia et al.|Blood Advances|2023Cited by 45